Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$41.99 - $62.38 $670,202 - $995,647
-15,961 Reduced 38.89%
25,078 $1.47 Million
Q3 2023

Nov 13, 2023

BUY
$27.8 - $45.35 $61,299 - $99,996
2,205 Added 5.68%
41,039 $1.79 Million
Q2 2023

Aug 10, 2023

BUY
$36.13 - $49.49 $264,001 - $361,623
7,307 Added 23.18%
38,834 $1.4 Million
Q1 2023

May 11, 2023

BUY
$36.54 - $54.26 $940,795 - $1.4 Million
25,747 Added 445.45%
31,527 $1.17 Million
Q4 2022

Feb 02, 2023

BUY
$41.27 - $98.62 $13,330 - $31,854
323 Added 5.92%
5,780 $261,000
Q3 2022

Nov 04, 2022

SELL
$59.5 - $86.7 $15,113 - $22,021
-254 Reduced 4.45%
5,457 $381,000
Q2 2022

Aug 01, 2022

SELL
$39.16 - $88.71 $18,757 - $42,492
-479 Reduced 7.74%
5,711 $383,000
Q1 2022

May 10, 2022

SELL
$75.82 - $150.97 $47,463 - $94,507
-626 Reduced 9.18%
6,190 $509,000
Q4 2021

Feb 08, 2022

SELL
$132.01 - $190.29 $83,694 - $120,643
-634 Reduced 8.51%
6,816 $1 Million
Q3 2021

Nov 12, 2021

BUY
$132.13 - $177.45 $984,368 - $1.32 Million
7,450 New
7,450 $1.32 Million
Q2 2021

Aug 12, 2021

SELL
$144.0 - $179.73 $188,352 - $235,086
-1,308 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$158.92 - $221.61 $62,932 - $87,757
396 Added 43.42%
1,308 $224,000
Q4 2020

Feb 09, 2021

BUY
$162.05 - $240.27 $147,789 - $219,126
912 New
912 $200,000

Others Institutions Holding MRTX

About Mirati Therapeutics, Inc.


  • Ticker MRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,609,800
  • Description
  • Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...
More about MRTX
Track This Portfolio

Track Profund Advisors LLC Portfolio

Follow Profund Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Profund Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Profund Advisors LLC with notifications on news.